Progeny 3 Inc Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHCA
Spindletop Health Acquisition Corp. Class A Common Stock
SHCA
|
+$14.9M |
| 2 |
MPLX
MPLX
|
+$13M |
| 3 |
Peabody Energy
BTU
|
+$11.4M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$11.2M |
| 5 |
Franco-Nevada
FNV
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHCAU
Spindletop Health Acquisition Corp. Unit
SHCAU
|
+$15.1M |
| 2 |
iShares MSCI Global Metals & Mining Producers ETF
PICK
|
+$4.89M |
| 3 |
LOGC
ContextLogic
LOGC
|
+$1.54M |
| 4 |
CGRN
Capstone Green Energy Corporation Common Stock
CGRN
|
+$39K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 40.74% |
| 2 | Technology | 16.24% |
| 3 | Materials | 10.02% |
| 4 | Financials | 7.64% |
| 5 | Consumer Discretionary | 0% |
Similar funds
Progeny 3 Inc's Q1 2022 Portfolio in Review
As of Q1 2022, Progeny 3 Inc held 27 positions worth $533M, up 44% from $370M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Progeny 3 Inc deployed $88.6M of net new capital in Q1 2022, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was Spindletop Health Acquisition Corp. Class A Common Stock: 1,500,000 shares worth $14.9M.
By sector, the portfolio is most concentrated in Energy at 41% of assets, up from 33% a quarter earlier, followed by Technology and Materials.
On the sell side, the most notable exit was Spindletop Health Acquisition Corp. Unit, an estimated $15.1M sold.
- Progeny 3 Inc's largest Q1 2022 buy was Spindletop Health Acquisition Corp. Class A Common Stock: 1,500,000 shares worth $14.9M.
- Progeny 3 Inc added most to MPLX in Q1 2022, an estimated $13M increase.
- Progeny 3 Inc fully exited Spindletop Health Acquisition Corp. Unit in Q1 2022, selling an estimated $15.1M.
- Progeny 3 Inc's ten largest holdings make up 81% of its $533M portfolio in Q1 2022.
- Progeny 3 Inc opened 4 new positions and closed 4 in Q1 2022.
- Progeny 3 Inc's portfolio value rose 44% quarter-over-quarter to $533M.
Based on Progeny 3 Inc's 13F filing for Q1 2022, filed 16 May 2022.